MP-E-8-3/1959

N/A

Report date: 2025/03/20 15:01:24

Base Information

Drug NameMP-E-8-3/1959
Drug Alias Namebispecific antibody targeted endosialin and LGALS3BP (MediaPharma/Pharmamab)bispecific antibody targeted endosialin and LGALS3BP (MediaPharma)dopo MP-E-8-3
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionGalectin-3-binding protein inhibitorsEndosialin inhibitorsGalanin receptor 3 antagonists
TargetsGalectin-3-binding proteinGalanin receptor 3Endosialin
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMedia Pharma SRL
China Registration ClassN/A

Develop Information

Active CompaniesPharmamab SrlMedia Pharma SRL
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A